Literature DB >> 32062824

The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins.

Fanqi Jin1, Fengshan Wang2.   

Abstract

In the past decades, the roles of carbohydrates in living organisms and their potential use in many fields have been extensively investigated. Sialyl Lewis x (sLex), a member of body carbohydrate, is an inherent blood-type tetrasaccharide on the surface of different cells, the lymphocyte, neutrophil, some T cells, multiple tumor cells and so on. SLex is a common ligand of the three selectins, L-selectin, E-selectin and P-selectin, and plays important roles in multiple physiological phenomenas by interacting with selectins. Under normal physiological conditions, sLex can affect the immune process and fertilization process. Lower expression of sLex could cause leukocyte adhesion defects (LAD) II. Overexpression of sLex on the other hand has been linked to several cancers including melanoma, breast, pancreatic, liver, lung, head and neck, ovarian, bladder carcinomas and some blood disease including Hodgkin disease, some B cell chronic lymphocytic leukemias, acute lymphoblastic leukemias, and most acute nonlymphocytic leukemias. This paper mainly reviews the physiological functions and pathological effects of sLex and its applications in disease diagnosis, drug delivery, gene transfer and medical molecular imaging. We aim to help researchers and other readers quickly grasp the physiological and pathological roles and its medical applications of sLex, and give some suggestions for research directions.

Entities:  

Keywords:  Cancer; Disease diagnosis; Drug delivery; Fertility; LAD II; Selectins; Sialyl Lewis x

Mesh:

Substances:

Year:  2020        PMID: 32062824     DOI: 10.1007/s10719-020-09912-4

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  124 in total

1.  Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.

Authors:  M Hirai; H Minematsu; Y Hiramatsu; H Kitagawa; T Otani; S Iwashita; T Kudoh; L Chen; Y Li; M Okada; D S Salomon; K Igarashi; M Chikuma; M Seno
Journal:  Int J Pharm       Date:  2010-03-06       Impact factor: 5.875

2.  ST3Gal III modulates breast cancer cell adhesion and invasion by altering the expression of invasion-related molecules.

Authors:  Hong-Xia Cui; Honglan Wang; Yuchun Wang; Juan Song; Hua Tian; Chunhui Xia; Yetong Shen
Journal:  Oncol Rep       Date:  2016-10-18       Impact factor: 3.906

3.  Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.

Authors:  Natalia R Kuznetsova; Eugenia V Stepanova; Nina M Peretolchina; Dmitry A Khochenkov; Ivan A Boldyrev; Nicolai V Bovin; Elena L Vodovozova
Journal:  J Drug Target       Date:  2013-12-09       Impact factor: 5.121

4.  Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis.

Authors:  Ariadna Sarrats; Radka Saldova; Eva Pla; Esther Fort; David J Harvey; Weston B Struwe; Rafael de Llorens; Pauline M Rudd; Rosa Peracaula
Journal:  Proteomics Clin Appl       Date:  2010-02-03       Impact factor: 3.494

5.  Impaired selectin-ligand biosynthesis and reduced inflammatory responses in beta-1,4-galactosyltransferase-I-deficient mice.

Authors:  Masahide Asano; Susumu Nakae; Norihiro Kotani; Naoki Shirafuji; Aya Nambu; Noriyoshi Hashimoto; Hiroto Kawashima; Mayumi Hirose; Masayuki Miyasaka; Seiichi Takasaki; Yoichiro Iwakura
Journal:  Blood       Date:  2003-04-24       Impact factor: 22.113

Review 6.  Targeting selectins and selectin ligands in inflammation and cancer.

Authors:  Steven R Barthel; Jacyln D Gavino; Leyla Descheny; Charles J Dimitroff
Journal:  Expert Opin Ther Targets       Date:  2007-11       Impact factor: 6.902

7.  A monoclonal antibody to human acute lymphoblastic leukaemia antigen.

Authors:  J Ritz; J M Pesando; J Notis-McConarty; H Lazarus; S F Schlossman
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

8.  One-pot multienzyme synthesis of Lewis x and sialyl Lewis x antigens.

Authors:  Hai Yu; Kam Lau; Yanhong Li; Go Sugiarto; Xi Chen
Journal:  Curr Protoc Chem Biol       Date:  2012-09-01

9.  E-selectin ligand complexes adopt an extended high-affinity conformation.

Authors:  Roland C Preston; Roman P Jakob; Florian P C Binder; Christoph P Sager; Beat Ernst; Timm Maier
Journal:  J Mol Cell Biol       Date:  2015-06-27       Impact factor: 6.216

10.  α-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation.

Authors:  Dongsheng Li; Hongzhi Sun; Guang Bai; Wei Wang; Miaomiao Liu; Zhiye Bao; Jingjing Li; Hao Liu
Journal:  Int J Mol Med       Date:  2018-08-31       Impact factor: 4.101

View more
  10 in total

1.  Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.

Authors:  Thomas Kolben; Lena Müller; Sarah Meister; Lucia Keilmann; Christina Buschmann; Fabian Trillsch; Alexander Burges; Bastian Czogalla; Sophie Mitter; Elisa Schmoeckel; Stefanie Corradini; Sven Mahner; Udo Jeschke; Mirjana Kessler; Susanne Beyer
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-21       Impact factor: 4.322

2.  Bisimidazolium Salt Glycosyltransferase Inhibitors Suppress Hepatocellular Carcinoma Progression In Vitro and In Vivo.

Authors:  Xue Luan; Ming Sun; Xue Zhao; Jingyi Wang; Ye Han; Yin Gao
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-05

Review 3.  Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment.

Authors:  Anna Y Berghuis; Johan F A Pijnenborg; Thomas J Boltje; Johanna M A Pijnenborg
Journal:  Int J Cancer       Date:  2021-11-17       Impact factor: 7.316

Review 4.  The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology.

Authors:  Marjolaine Hugonnet; Pushpita Singh; Quentin Haas; Stephan von Gunten
Journal:  Front Immunol       Date:  2021-12-17       Impact factor: 7.561

Review 5.  Glycans as Targets for Drug Delivery in Cancer.

Authors:  Francisca Diniz; Pedro Coelho; Henrique O Duarte; Bruno Sarmento; Celso A Reis; Joana Gomes
Journal:  Cancers (Basel)       Date:  2022-02-12       Impact factor: 6.639

Review 6.  Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives.

Authors:  Nora Berois; Alvaro Pittini; Eduardo Osinaga
Journal:  Cancers (Basel)       Date:  2022-01-27       Impact factor: 6.639

7.  miR‑519d‑3p released by human blastocysts negatively regulates endometrial epithelial cell adhesion by targeting HIF1α.

Authors:  Xiaodan Wang; Suibing Miao; Linqi Lu; Jingchuan Yuan; Shuhong Pan; Xiaohua Wu
Journal:  Int J Mol Med       Date:  2022-08-12       Impact factor: 5.314

8.  Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 Inhibition.

Authors:  Peter Petzelbauer
Journal:  Int J Mol Sci       Date:  2020-11-06       Impact factor: 5.923

9.  Oxygen conditions oscillating between hypoxia and hyperoxia induce different effects in the pulmonary endothelium compared to constant oxygen conditions.

Authors:  Peter Wohlrab; Michael Johann Danhofer; Wolfgang Schaubmayr; Akos Tiboldi; Katharina Krenn; Klaus Markstaller; Roman Ullrich; Klaus Ulrich Klein; Verena Tretter
Journal:  Physiol Rep       Date:  2021-02

Review 10.  Unique Tropism and Entry Mechanism of Mumps Virus.

Authors:  Marie Kubota; Takao Hashiguchi
Journal:  Viruses       Date:  2021-09-01       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.